Computer-assisted quantitative evaluation of bisphosphonate treatment for Paget's disease of bone using the bone scan index

Nagano,Satoshi; Nakamura,Shunsuke; Shimada,Hirofumi; Yokouchi,Masahiro; Setoguchi,Takao; Ishidou,Yasuhiro; Sasaki,Hiromi; Komiya,Setsuro

doi:10.3892/etm.2016.3899

Computer-assisted quantitative evaluation of bisphosphonate treatment for Paget's disease of bone using the bone scan index

Authors:
- Satoshi Nagano
- Shunsuke Nakamura
- Hirofumi Shimada
- Masahiro Yokouchi
- Takao Setoguchi
- Yasuhiro Ishidou
- Hiromi Sasaki
- Setsuro Komiya
View Affiliations

Affiliations: Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890‑8520, Japan, The Near‑Future Locomotor Organ Medicine Creation Course (Kusunoki Kai), Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890‑8520, Japan, Department of Medical Joint Materials, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890‑8520, Japan
Published online on: November 14, 2016 https://doi.org/10.3892/etm.2016.3899
Pages: 3830-3836
Copyright: © Nagano et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to analyze the effect of treatment of Paget's disease of bone (PDB) with bone scintigraphy using a computer‑assisted diagnosis system (BONENAVI) that quantitatively evaluates bone metabolism. Seven patients with PDB (three male, four female; average age, 60 years; age range, 33‑80 years) underwent bone scintigraphy and measurement of serum alkaline phosphatase (ALP), bone‑specific ALP (BAP), serum cross‑linked N‑telopeptide (NTx) of type I collagen, urinary NTx, and deoxypyridinoline (DPD) before and after bisphosphonate treatment. Bone scan index (BSI), artificial neural network (ANN) value, and hotspot number (HSn) were calculated using BONENAVI software. Mean follow‑up period was 22 months (range, 11‑35 months). Among three BONENAVI parameters (ANN, BSI, and HSn), only BSI was significantly lower after bisphosphonate treatment as compared with before. All bone metabolic markers excluding DPD were significantly lower following bisphosphonate treatment than before. Bone formation markers (ALP and BAP) were significantly lower than bone resorption markers (U‑NTx and S‑NTx). The correlation of BONENAVI parameters with four bone metabolic markers was analyzed before and after bisphosphonate treatment. Before treatment, the majority of the four markers did not correlate with the BONENAVI parameters. In contrast, post‑treatment ALP, BAP, and U‑NTx were significantly correlated with BSI and HSn. To the best of our knowledge, this is the first study to evaluate the treatment of PDB by bone scintigraphy using a computer‑assisted diagnosis system that quantitatively evaluates bone metabolism. The findings demonstrated that, using BONENAVI software, bone scintigraphy is able to quantitatively and spatially evaluate the bisphosphonate treatment effect, particularly in patients with polyostotic PDB.

View Figures

View References

1	Hashimoto J, Ohno I, Nakatsuka K, Yoshimura N, Takata S, Zamma M, Yabe H, Abe S, Terada M, Yoh K, et al: Prevalence and clinical features of Paget's disease of bone in Japan. J Bone Miner Metab. 24:186–190. 2006. View Article : Google Scholar : PubMed/NCBI
2	Langston AL and Ralston SH: Management of Paget's disease of bone. Rheumatology (Oxford). 43:955–959. 2004. View Article : Google Scholar : PubMed/NCBI
3	Ralston SH, Langston AL and Reid IR: Pathogenesis and management of Paget's disease of bone. Lancet. 372:155–163. 2008. View Article : Google Scholar : PubMed/NCBI
4	Scutellari PN, Giorgi A, De Sario V and Campanati P: Correlation of multimodality imaging in Paget's disease of bone. Radiol Med. 110:603–615. 2005.(In English, Italian). PubMed/NCBI
5	Sadik M, Jakobsson D, Olofsson F, Ohlsson M, Suurkula M and Edenbrandt L: A new computer-based decision-support system for the interpretation of bone scans. Nucl Med Commun. 27:417–423. 2006. View Article : Google Scholar : PubMed/NCBI
6	Sadik M, Hamadeh I, Nordblom P, Suurkula M, Höglund P, Ohlsson M and Edenbrandt L: Computer-assisted interpretation of planar whole-body bone scans. J Nucl Med. 49:1958–1965. 2008. View Article : Google Scholar : PubMed/NCBI
7	Wakabayashi H, Nakajima K, Mizokami A, Namiki M, Inaki A, Taki J and Kinuya S: Bone scintigraphy as a new imaging biomarker: The relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases. Ann Nucl Med. 27:802–807. 2013. View Article : Google Scholar : PubMed/NCBI
8	Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, Makino T and Koyama M: Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann Nucl Med. 29:138–148. 2015. View Article : Google Scholar : PubMed/NCBI
9	Horikoshi H, Kikuchi A, Onoguchi M, Sjöstrand K and Edenbrandt L: Computer-aided diagnosis system for bone scintigrams from Japanese patients: Importance of training database. Ann Nucl Med. 26:622–626. 2012. View Article : Google Scholar : PubMed/NCBI
10	Takata S, Hashimoto J, Nakatsuka K, Yoshimura N, Yoh K, Ohno I, Yabe H, Abe S, Fukunaga M, Terada M, et al: Guidelines for diagnosis and management of Paget's disease of bone in Japan. J Bone Miner Metab. 24:359–367. 2006. View Article : Google Scholar : PubMed/NCBI
11	Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, Makino T and Koyama M: Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann Nucl Med. 29:138–148. 2015. View Article : Google Scholar : PubMed/NCBI
12	Kikushima S, Hanawa N and Kotake F: Diagnostic performance of bone scintigraphy analyzed by three artificial neural network systems. Ann Nucl Med. 29:125–131. 2015. View Article : Google Scholar : PubMed/NCBI
13	Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES and Scher HI: A new parameter for measuring metastatic bone involvement by prostate cancer: The bone scan index. Clin Cancer Res. 4:1765–1772. 1998.PubMed/NCBI
14	Tokuda O, Harada Y, Ohishi Y, Matsunaga N and Edenbrandt L: Investigation of computer-aided diagnosis system for bone scans: A retrospective analysis in 406 patients. Ann Nucl Med. 28:329–339. 2014. View Article : Google Scholar : PubMed/NCBI
15	Takahashi Y, Yoshimura M, Suzuki K, Hashimoto T, Hirose H, Uchida K, Inoue S, Koizumi K and Tokuuye K: Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods. Ann Nucl Med. 26:586–593. 2012. View Article : Google Scholar : PubMed/NCBI
16	Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD and Cundy T: Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone. Bone. 35:224–230. 2004. View Article : Google Scholar : PubMed/NCBI
17	Shankar S and Hosking DJ: Biochemical assessment of Paget's disease of bone. J Bone Miner Res. 21:(Suppl 2). P22–P27. 2006. View Article : Google Scholar : PubMed/NCBI
18	Papapoulos SE and Frölich M: Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption. J Clin Endocrinol Metab. 81:3993–3997. 1996. View Article : Google Scholar : PubMed/NCBI
19	Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, de Osaba MJ Martinez, Muñoz-Gomez J, Rivera-Fillat F and Ballesta AM: Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. J Bone Miner Res. 10:458–465. 1995. View Article : Google Scholar : PubMed/NCBI
20	Iwase T, Yamamoto N, Ichihara H, Togawa T, Nagashima T and Miyazaki M: The relationship between skeletal-related events and bone scan index for the treatment of bone metastasis with breast cancer patients. Medicine (Baltimore). 93:e2692014. View Article : Google Scholar : PubMed/NCBI